Jazz Pharmaceuticals plc DEFA14A, filed Jul 22, 2020
Jazz Pharmaceuticals plc (JAZZ)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to Section 240.14a-12 |
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
| ☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| 1) | Title of each class of securities to which transaction applies: |
| 2) | Aggregate number of securities to which transaction applies: |
| 3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
| 4) | Proposed maximum aggregate value of transaction: |
| 5) | Total fee paid: |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
| 1) | Amount Previously Paid: |
| 2) | Form, Schedule or Registration Statement No.: |
| 3) | Filing Party: |
| 4) | Date Filed: |
Subject: Action Requested of Jazz Employee Shareholders – Please Vote Your Shares!
Dear Jazzicians,
We are holding our 2020 Annual General Meeting of Shareholders on July 30th, and many of you are shareholders in addition to being employees of Jazz Pharmaceuticals.
If you held Jazz shares as of June 3, 2020 (the record date), you should have received instructions in the mail or electronically from E*Trade or your personal broker about how to vote your shares. The E*Trade email regarding our 2020 Annual Meeting contains a “Vote Now” button which directs you to a landing page where you can vote your shares (please check your “spam” or ‘junk” folder if you did not receive it). If you do not receive electronic communications from E*Trade, you should have received instructions about how to vote your shares in the mail.
We have a number of important proposals being voted on this year. Jazz’s board of directors and management team recommend that you vote your shares “FOR” the election of each of the director nominees that have been nominated for re-election, and “FOR” each of the other proposals that have been submitted for a shareholder vote. Please refer to Jazz Pharmaceuticals’ proxy statement for more details regarding the nominees and proposals, or reach out to me or Doris Choi.
As a Jazz shareholder, your vote is very important. We encourage you to read the proxy statement and vote your shares as soon as possible. If you require any assistance in voting your shares, please call Alliance Advisors, our proxy solicitor, at +1.855.600.8108.
We thank all of you for your continued support of Jazz Pharmaceuticals.
Neena Patil
Senior Vice President and General Counsel
